Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

A potential role for psilocybin in the treatment of obsessive-compulsive disorder

Bibliographic Data

ID4616033
AuthorsEdward Jacobs (0000-0002-2622-7233, King's College London, corresponding author)
Year2020
Volume4
Issue2
Pages77-87
Publication date2020-06-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Psychedelic Studies (JOURNAL)
Journal identifiersISSN: 2559-9283 • E-ISSN: 2559-9283
PublisherAkademiai Kiado Zrt (PUBLISHER)
DOI10.1556/2054.2020.00128
OpenAlexW3048223422
LanguageEN
Citations received1
References cited119

The recent revivification of interest in the therapeutic use of psychedelics has had a particular focus on mood disorders and addiction, although there is reason to think these drugs may be effective more widely. After outlining pertinent aspects of psilocybin and obsessive-compulsive disorder (OCD), the current review summarizes the evidence indicating that there may be a role for psilocybin in the treatment of OCD, as well as highlighting a range of potential therapeutic mechanisms that reflect the action of psilocybin on brain function. Although the current evidence is limited, that multiple signals point in directions consistent with treatment potential, alongside the psychological and physiological safety of clinically administered psilocybin, support the expansion of research, both in animal models and in further randomized controlled trials, to properly investigate this potential

Addiction · Hallucinogen · Mood · Obsessive compulsive · Psilocybin · Psychiatry · Psychotherapist · Body Image and Dysmorphia Studies · Clinical Psychology · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology

  • Psychedelic therapy for body dysmorphic disorder

    Open Access•Shevaugn Johnson, C Letheby•Journal of Psychedelic Studies•2022

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Journal of Psychopharmacology•2016

  • Survey study of challenging experiences after ingesting psilocybin mushrooms

    Open Access•Theresa M Carbonaro, Matthew P Bradstreet et al.•Journal of Psychopharmacology•2016

  • Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

    Open Access•Frederick S Barrett, Matthew W Johnson et al.•Journal of Psychopharmacology•2015

  • Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

    Albert Garcia-Romeu, Albert Garcia‐Romeu et al.•Current Drug Abuse Reviewse•2015

  • The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

    Open Access•Ayelet Meron Ruscio, Dan J Stein et al.•Molecular Psychiatry•2010

  • Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

    Open Access•Robin Carhart‐Harris, Robin L Carhart-Harris et al.•Proceedings of the National…•2012

  • Psilocybin with psychological support for treatment-resistant depression

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Psychopharmacology•2018

  • Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

    Open Access•Leor Roseman, David Nutt et al.•Frontiers in Pharmacology•2018

  • Predicting Responses to Psychedelics

    Open Access•Eline C H M Haijen, Eline Haijen et al.•Frontiers in Pharmacology•2018

  • Psychedelics not linked to mental health problems or suicidal behavior

    Open Access•Pål-Ørjan Johansen, Teri Suzanne Krebs•Journal of Psychopharmacology•2015

  • Human hallucinogen research

    Open Access•MW Johnson, WA Richards et al.•Journal of Psychopharmacology•2008

  • The Brain's Default Network

    Open Access•Randy L Buckner, Jessica R Andrews‐Hanna et al.•Annals of the New York Academy of…•2008

  • Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

    Charles S Grob, Alicia Danforth et al.•Archives of General Psychiatry•2011

  • Obsessional-compulsive problems

    Open Access•Paul M Salkovskis•Behaviour Research and Therapy•1985

  • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer

    Open Access•Stephen Ro, Stephen Ross et al.•Journal of Psychopharmacology•2016

  • Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

    Open Access•Peter S Hendricks, Christopher B Thorne et al.•Journal of Psychopharmacology•2015

  • Psychedelic therapy for smoking cessation

    Open Access•T Noorani, Albert Garcia-Romeu et al.•Journal of Psychopharmacology•2018

  • Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder

    Francisco Moreno, Francisco A Moreno et al.•The Journal of Clinical Psychiatry•2006

  • Psychedelics and Mental Health

    Open Access•Teri Suzanne Krebs, Pål-Ørjan Johansen et al.•PLoS ONE•2013

  • Set and setting, psychedelics and the placebo response

    Open Access•Ido Hartogsohn•Journal of Psychopharmacology•2016

  • Hallucinogens

    Open Access•David E Nichols•Pharmacology & Therapeutics•2004

  • Psychedelics Promote Structural and Functional Neural Plasticity

    Open Access•Calvin Ly, Alexandra C Greb et al.•Cell Reports•2018

  • Rebus and the Anarchic Brain

    Open Access•Robin Carhart‐Harris, R L Carhart-Harris et al.•Pharmacological Reviews•2019

  • Long-term follow-up of psilocybin-facilitated smoking cessation

    Matthew W Johnson, Albert Garcia-Romeu et al.•The American Journal of Drug and…•2017

  • Psychedelics and the essential importance of context

    Open Access•Robin L Carhart-Harris, Leor Roseman et al.•Journal of Psychopharmacology•2018

  • Psychedelics

    Open Access•David E Nichols•Pharmacological Reviews•2016

  • Psilocybin occasioned mystical-type experiences

    Open Access•Roland R Griffiths, Matthew W Johnson et al.•Psychopharmacology•2011

  • Psilocybin-assisted treatment for alcohol dependence

    Open Access•Michael P Bogenschutz, Alyssa A Forcehimes et al.•Journal of Psychopharmacology•2015

  • Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety

    Open Access•A K Davis, Frederick S Barrett et al.•Journal of Contextual Behavioral…•2019

  • Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II

    Open Access•James B Close, Eline C Hajien et al.•Journal of Contextual Behavioral…•2020

  • Increased Default Mode Network Connectivity in Obsessive–Compulsive Disorder During Reward Processing

    Open Access•Kathrin Koch, Tim Jonas Reeß et al.•Frontiers in Psychiatry•2018

  • Acid Dreams

    Robert Leverant•Journal of Psychoactive Drugs•1987

  • Psilocybin and Obsessive Compulsive Disorder

    James Allen Wilcox•Journal of Psychoactive Drugs•2014

  • Acid Dreams

    Richard H Immerman, Martin A Lee et al.•Journal of American History•1987

  • Drugs and Mysticism

    Open Access•Jacques Binet•Diogenes•1974

Unique citing works1
Citations per year0,25
Citation span2022 - 2022 (1)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 1

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae